Type 2 diabetes mellitus and postmenopausal osteoporosis: how to improve the quality of life?

DOI: https://doi.org/10.29296/25877305-2019-11-17
Download full text PDF
Issue: 
11
Year: 
2019

Professor M. Sergeeva-Kondrachenko(1), MD; Professor V. Strukov(1), MD; P. Poluboyarinov(2), Candidate of Agricultural Sciences; E. Petrova(3), Candidate of Medical Sciences 1-Penza Institute for Postgraduate Training of Physicians, Branch, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia 2-Penza State University of Architecture and Construction

Effective control of type 2 diabetes mellitus (T2DM) and postmenopausal osteoporosis (OP) remains an urgent problem, despite the large arsenal of drugs used in the therapy of these patients. The quality of life (QOL) in patients is one of the new criteria for assessing the quality of medical care, which has become widespread in recent years. The objective of the investigation was to assess QOL in patients with T2DM and postmenopausal OP according to the therapy of postmenopausal OP, by using the SF-36 Heath Status Survey questionnaire. A total of 84 patients with T2DM and postmenopausal OP were surveyed. The mean age of the examinees was 55.7±4.1 years. The higher QOL in patients with T2DM and postmenopausal OP was associated with the use of Osteomed Forte.

Keywords: 
endocrinology
type 2 diabetes mellitus
quality of life
postmenopausal osteoporosis
SF-36 Heath Status Survey qestionnaire
Osteomed Forte



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Birjukova E. V. Osteoporoz: tochka zrenija endokrinologa // Farmateka. – 2012; 1-12: 32–9 [Biryukova E.V. Osteoporosis: Point Of View Of Endocrinologist // Farmateka. – 2012; 1-12: 32–9 (in Russ.)].
  2. Grigorjan O.R., Andreeva E.N. Menopauzal'nyj sindrom u zhenschin s narushenijami uglevodnogo obmena. Al'ternativnye i dopolnitel'nye metody terapii v klimakterii (obzor literatury) // Ginekologija. – 2011; 3: 4–7 [Grigoryan O.R., Andreeva E.N. Menopausal syndrome in women with impaired glucose metabolism. Alternative and complementary therapies in menopause (literature review) // Ginekologiya. – 2011; 3: 4–7 (in Russ.)].
  3. Rozhinskaja L. Ja. Osteopenicheskij sindrom pri zabolevanijah endokrinnoj sistemy i postmenopauzal'nyj osteoporoz (patogeneticheskie as-pekty, diagnostika i lechenie). Dis. … d-ra med. nauk. M., 2001; 318 s. [Rozhinskaya L. Ya. Osteopenicheskii sindrom pri zabolevaniyakh endokrinnoi sistemy i postmenopauzal’nyi osteoporoz (patogeneticheskie as-pekty, diagnostika i lechenie). Dis. … d-ra med. nauk. M., 2001; 318 s. (in Russ.)].
  4. Sergeeva-Kondrachenko M.Ju., Bolotina T.P. Kachestvo zhizni bol'nyh s saharnym diabetom 2 tipa. Aktual'nye voprosy diagnostiki, lechenija i reabilitatsii bol'nyh. Mat-ly XVII nauchno-prakt. konf. s mezhdunar. uchast. Sb. statej / Penza, 2014; s. 170–1 [Sergeeva-Kondrachenko M.Yu., Bolotina T.P. Kachestvo zhizni bol’nykh s sakharnym diabetom 2 tipa. Aktual’nye voprosy diagnostiki, lecheniya i reabilitatsii bol’nykh. Mat-ly XVII nauchno-prakt. konf. s mezhdunar. uchast. Sb. statei / Penza, 2014; s. 170–1 (in Russ.)].
  5. Strukov V., Elistratov D., Kislov A. i dr. Osteoporoz v geriatricheskoj praktike // Vrach. – 2018; 29 (6): 26–30 [Strukov V., Elistratov D., Kislov A. et al. Osteoporosis in geriatric practice // Vrach. – 2018; 29 (6): 26–30 (in Russ.)]. https://doi.org/10.29296/25877305-2018-06-05
  6. Dzhouns O., Strukov V., Kislov A. i dr. Komorbidnyj osteoporoz: problemy i novye vozmozhnosti terapii (ch. 2) // Vrach. – 2017; 11: 25–9 [Jones O., Strukov V., Kislov A. et al. Comorbid osteoporosis: challenges and new diagnostic opportunities (Part 2) // Vrach. – 2017; 11: 25–9 (in Russ.)].
  7. Strukov V.I., Sergeeva-Kondrachenko M.Ju. Aktual'nye problemy osteoporoza / Penza: Tipografija – ROSTRA, 2009; 342 s. [Strukov V.I., Sergeeva-Kondrachenko M.Yu. Aktual’nye problemy osteoporoza / Penza: Tipografiya – ROSTRA, 2009; 342 s. (in Russ.)].
  8. Pushkarev L.A., Arinchina N.G. Metodika otsenki kachestva zhizni bol'nyh i invalidov: metod. rekomend. / Mn.: BNIIETIN, 2000; 16 s. [Pushkarev L.A., Arinchina N.G. Metodika otsenki kachestva zhizni bol’nykh i invalidov: metod. rekomend. / Mn.: BNIIETIN, 2000; 16 s. (in Russ.)].
  9. Hetagurova A.K. Voprosy kachestva zhizni v sovremennoj palliativnoj meditsine // Vopr. upravlen. zdravoohr . – 2003; 6 (13): 49–50 [Khetagurova A.K. Voprosy kachestva zhizni v sovremennoi palliativnoi meditsine // Vopr. upravlen. zdravookhr . – 2003; 6 (13): 49–50 (in Russ.)].
  10. Yaturu S., Humphrey S., Landry C. et al. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes // Med. Sci. Monit. – 2009; 15 (1): CR5–9.
  11. Nicodemus K., Folsom A.; Iowa Women’s Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women // Diabetes Care. – 2001; 24 (7): 1192–7. DOI: 10.2337/diacare.24.7.1192.
  12. Melton L. 3rd, Leibson C., Achenbach S. et al. Fracture risk in type 2 diabetes: update of a population-based study // J. Bone Miner. Res. – 2008; 23 (8): 1334–42. DOI: 10.1359/jbmr.080323.